Home ›› Tools ›› Author Institution Mapping

Select the journal to see authorsí institution mapping (AIM) for the latest issue
Select journal
Perspectives in Clinical Research

Table of Contents RSS Feed
2018| October-December  | Volume 9 | Issue 4  

Please wait, loading Google Map...

EDITORIAL  
Drug-resistant tuberculosis – A ticking time bomb! p. 153
Srikanth Krishnamurthy
[ABSTRACT]  [HTML Full text]  [PDF]
ORIGINAL ARTICLES Top
Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications p. 155
Pradeep Gadge, Roshani Gadge, Nikita Paralkar, Preeti Jain, Vrunda Tanna
[ABSTRACT]  [HTML Full text]  [PDF]
Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne p. 161
Swapnil Narayan Deshmukh, Vandana Avinash Badar, Manali Mangesh Mahajan, D Sujata Dudhgaonkar, Dharmendra Mishra
[ABSTRACT]  [HTML Full text]  [PDF]
Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot p. 165
Kiran Gordhanbhai Piparva, Gaurav Jansari, Anil P Singh
[ABSTRACT]  [HTML Full text]  [PDF]
REVIEW ARTICLES Top
Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices p. 170
Mohit Hans, Suresh Kumar Gupta
[ABSTRACT]  [HTML Full text]  [PDF]
Materiovigilance: An Indian perspective p. 175
Bikash Ranjan Meher
[ABSTRACT]  [HTML Full text]  [PDF]
INVESTIGATOR INSIGHTS Top
Investigator-initiated studies: Challenges and solutions p. 179
Mahanjit Konwar, Debdipta Bose, Nithya J Gogtay, Urmila M Thatte
[ABSTRACT]  [HTML Full text]  [PDF]
STATISTICS Top
Study designs: Part 1 – An overview and classification p. 184
Priya Ranganathan, Rakesh Aggarwal
[ABSTRACT]  [HTML Full text]  [PDF]
LETTER TO EDITOR Top
From “Glivec®” to “Prevnar 13®”: How strong is the Indian drug patenting system? p. 187
Gerard Marshall Raj
[ABSTRACT]  [HTML Full text]  [PDF]